nosed AD (odds ratio = 2.93, 95% confidence interval = 2.22-3.86). These results were independent from the gender of the patient or informant, whether the informant lived with the patient, and other patient characteristics, such as dementia severity, depressive symptoms, and NPI-Q-derived measures of hallucinations, delusions, agitation and apathy. In AD, but not DLB, patients, NSD was associated with more advanced disease. Comorbidity of NSD with hallucinations, agitation and apathy was higher in DLB than in AD. There was also evidence that the percentage of DLB cases with NSD showed wide variation across centers. Conclusion: As defined by the NPI-Q, endorsement of the nocturnal behavior item by informants is more likely in patients with DLB when compared to AD, even after the adjustment of key patient/informant characteristics.
Introduction
Sleep disturbance occurs in many forms of dementia; however, it is possible that certain forms of dementia may be relatively more likely to be associated with disturbed sleep. For example, the Third International Consensus Conference definition of dementia with Lewy bodies (DLB) [1] indicates that rapid eye movement (REM) sleep behavior disorder (RBD) may be important in defining this condition. Although patients with Alzheimer's disease (AD) have also been known to have disrupted sleep [2] and may experience changes in circadian rhythms [2, 3] , few studies have compared the presence of disturbed sleep between these two neurodegenerative conditions. In this study, we report on a comparison of informantreported nighttime behaviors in secondary data analyses of a large national database of well-characterized patients with AD and DLB using the National Institute on Aging (NIA) Uniform Data Set (UDS).
Methods
Data in this study were derived from the UDS covering the period of September 2005 to November 2008 maintained by the National Alzheimer's Coordinating Center (NACC) located at the University of Washington under the auspices of the NIA. Development of the UDS has been described elsewhere [4, 5] but, in brief, consists of a deidentified, web-based, relational database, which serves as a repository for data collected by the 32 NIAfunded AD centers. Access to the NACC UDS database is available to all interested researchers associated with an NIA-sponsored AD research center via formal request to the NACC Steering Committee through the NACC website (https://www.alz.washington.edu; see Beekly et al. [4] and Lau et al. [6] for further information).
All patients or their proxies provided informed consent through an Institutional Review Board-approved protocol at each site. All patients entered in the UDS received a physician-based clinical diagnosis. Autopsy verification is pursued in many centers as a part of the NACC data collection but was not incorporated into the analyses presented here. As is customary of patients encountered in clinics focusing on dementias, a broad range of diagnoses are considered. In this study, analyses were limited to cases with a diagnosis of DLB or probable AD. Clinical diagnosis for each of these conditions followed consensus-based definitions and criteria [1, 7, 8] . Additional data employed in the study were patient and informant demographics (e.g. gender, age, and education), the 15-item form of the Geriatric Depression Scale (GDS) [9] and the Mini-Mental State Exam [10] . The Clinical Dementia Rating (CDR) [11] was used to rate the severity of each patient's dementia, calculated as the sum of boxes (SOB). Finally, we relied upon an informant-derived measure dealing with behavioral syndromes common in dementia patients, i.e. the Neuropsychiatric Inventory Questionnaire (NPI-Q) [12, 13] , which has been validated in AD patients, though not necessarily DLB patients [13] . The NPI-Q requires that the informant report on the patient's behaviors during the preceding month, which also entails severity, and is included as a part of the UDS. As described on the NACC website, one of the aims of the UDS is to ensure high-quality assurance for all data collected, and to that end, the NPI-Q is completed by a trained health professional via informant interview. In some cases, adult children of the patients served as informants.
We focused on several specific items on the NPI-Q, including the presence or absence of agitation/aggression, hallucinations, delusions, nighttime behaviors, apathy, and depressed mood. The nighttime behavior item was: 'Does the patient awaken you at night, rise too early in the morning, or take excessive naps during the day?', which could be answered with 'yes' or 'no' (see Cummings et al. [12] for specific wording of other NPI-Q items). Informant responses to this item were categorized as positive or negative for nighttime sleep disturbance (NSD). Although clinical diagnoses in the UDS are based on expert consensus at each participating center, the possibility exists that information related to sleep gathered on the NPI-Q may also have been used diagnostically at some centers. To quantify the association between diagnosis and NSD, a multivariate logistic regression model was developed using data from all 32 centers. This model also accounted for patient characteristics (age, gender, race, marital status), informant gender, NPI-Q items (depression, hallucinations, delusions, agitation, apathy), and CDR SOB. Because it was of interest to investigate center differences, center ID was included as an adjustment variable and not accounted for as a random effect. All covariates, except CDR SOB, were categorical and modeled as a series of binary variables. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to summarize the model. The robustness of these estimates was assessed by refitting the model on data derived from patients that were living with others. All analyses were performed using R version 2.11 [14] .
Statistical Analyses

Results
As of November 1, 2008, 4,444 patients with a primary diagnosis of probable AD and 354 patients with a primary diagnosis of DLB were available for analysis. Of these patients, 4,531 (94%) had complete NPI-Q data and served as the basis for the current work. DLB (4.2%) and AD (5.7%) patients did not differ in the proportions of missing NPI-Q data Table 1 compares patient and informant characteristics for patients with and without NSD by diagnosis. Results suggest that among probable AD patients, those with NSD were more likely to be older and black, whereas among DLB patients, those with NSD were more likely to be male and married. Few other patient or informant characteristics appeared to distinguish diagnostic groups having or not having NSD.
Differences among centers were apparent. Of the 13 centers reporting 9 or more DLB cases, the presence of NSD ranged from 22.2 to 80.0%. The frequencies of NSD in all centers and their 95% bootstrapped CI are presented in figure 1 and suggest that, along with wide CI among some centers contributing only a small number of cases, there was considerable variation in the presence of NSD in DLB by center, relative to the presence of NSD in AD. Table 2 examines the extent to which dementia severity and depressive symptoms may have differentiated patients with informant-reported NSD from those without NSD. The CDR SOB was significantly higher in AD patients with informant-reported NSD, but this relationship was not seen in DLB, implying that in AD patients NSD may be a late-stage, rather than early-stage, disease correlate. Higher depression scores were also associated with NSD in AD, but not DLB, patients.
Informant-reported NSD was also associated with several other key aspects of behavioral disturbance on the NPI-Q, including delusions, hallucinations, agitation and apathy ( table 3 ) . These informant-reported phenomena were associated with informant-reported NSD in both DLB and AD. It is noteworthy that the comorbidities between these phenomena were higher in DLB, relative to AD patients, implying that such behavioral manifestations are more likely to represent an overlapping, common phenotype in the former, relative to the latter. The nonmotor symptoms of DLB may thus constitute a more recognizable constellation of behaviors than they do in AD, where such phenomena may be more likely to occur in a somewhat more isolated fashion.
The regression summary (OR and 95% CI) is presented in table 4 . Because there were fewer cases missing NPI-Q items relative to missing data with the GDS, we included the NPI-Q depressed mood item in this model. These data suggested that although older age, male gender, black race, CDR SOB, and NPI-Q-derived assessments of depressive symptoms, hallucinations, delusions, agitation and apathy were associated with NSD, the presence of DLB diagnosis was by far the strongest predictor (OR = 2.93, 95% CI = 2.22-3.86). Significant differences were also noted among a few of the centers. Data were virtually identical when cases living alone were excluded (OR for diagnosis = 3.18, 95% CI = 2.39-4.23), suggesting that inclusion of those cases did not influence this association.
Discussion
These data indicate that substantial proportions of DLB and AD patients experience some aspect of disturbed sleep, with the former showing an apparent presence well over twice that of the latter. The data thus confirm what preliminary analyses in much smaller samples of such patients from particular sites [15] [16] [17] [18] [19] and of patients with more generally defined parkinsonism [20] have demonstrated previously. Patients with DLB are more likely to suffer from NSD than patients with AD. The neurobiological substrates for the preferential association of sleep disturbance with synucleinopathies versus amyloidopathies remain speculative, but are thought to involve the primacy of brainstem degeneration in parkinsonian-like conditions [17, 21, 22] . Such deterioration may impact upon nuclei such as the pedunculopontine nucleus, the sublaterodorsal nucleus, the magnocellular reticular formation, or other structures and their afferent/efferent projections, which ultimately lead to dysregulation of normal REM sleep atonia [21, 23] . Among the AD patients, but not the DLB patients, NSD was more likely to be associated with more advanced disease (i.e., CDR). This is consistent with the observation that sleep disturbance may be one of the earliest signs of a synucleinopathy [24] and one that remains prominent throughout disease course or may even decrease [25] , whereas in AD it may be a sign of late-stage disease [26, 27] .
Hypersomnolence as captured by a positive response to the phrase on the NPI-Q 'take excessive naps during the day' could reflect a circadian dysrhythmia, coexistent obstructive and/or central sleep apnea syndrome, restless legs syndrome/periodic limb movement disorder, a narcolepsy-like disorder, another primary sleep disorder, or an effect of medications. It may also reflect apathy, which Var iables are summarized as percentages and comparisons within diagnosis by NSD were computed using Pearson's test. A 'yes' response on 'reliability' refers to cases for whom credibility of the informant may be questionable. may overlap with sleepiness to some degree. The frequencies of these various sleep disorders among DLB and AD patients are not well characterized, but these warrant further study, as they could be differentially expressed in DLB versus AD and provide diagnostic clues. Furthermore, as reflected by endorsement of frequent napping, hypersomnolence could contribute to the fluctuations in cognition and/or arousal which are considered a core feature of DLB [17] .
Weaknesses of the current analyses include the fact that the UDS database essentially represents a convenience sample of patients presenting at academic AD centers, lack of autopsy verification of clinical diagnosis, lack of control over medication usage and daytime activity level, as well as the limitation of the NPI-Q as the sole source of information regarding nocturnal behavior. There are many disadvantages of the NPI-Q nighttime behavior item. The NPI-Q was selected for inclusion in the UDS because of its demonstrated utility and validity in gathering data on a wide variety of behavioral syndromes associated with dementia [12] , but its use was not driven specifically by an interest in sleep or sleep behavior. We could locate only one very preliminary study reporting convergent validity of the NPI-Q sleep item with other sleep questions, which themselves were summarized globally into a single score [28] . The fundamental limitation of the item is that it consists of three separate, undifferentiated components (nocturnal awakenings, arising too early in the morning, or excessive daytime napping), which may or may not occur concurrently in dementia patients [2, [29] [30] [31] . (The final component, daytime sleepiness, arguably does not even constitute a 'nighttime' behavior, though one might infer that it could represent an outcome of poor sleep at night [32, 33] . Our finding that informant-endorsed apathy on the NPI-Q also overlapped with the nighttime behavior item further suggests possible overlap with daytime sleepiness). Furthermore, none of these three components implicit within the single question specifically target dream enactment behaviors during REM (so-called 'active sleep') that constitute one of the suggestive criteria (i.e., the behavioral manifestation of RBD) for DLB diagnosis [1] . Such an omission could represent a 'false negative'.
Of consequence in the current work is that the more likely presence of NSD in DLB relative to AD was a robust finding. It occurred independently from the patient's gender or the informant's gender. It also occurred regardless of whether the informant lived with or was married to the patient. Various centers also differed in the presence of NSD at their respective sites, particularly for DLB cases. Among the 13 centers encountering 9 or more DLB cases, informant-endorsed NSD ranged from as low as 22% (center 27) to as high as 81% (center 18) ( fig. 1 ) , whereas the range for NSD in AD cases among those same centers was about half of that (as low as 17% for center 7 to as high as 42% for center 24). Informant endorsement variability can be interpreted in several different ways. It is possible that DLB patients at certain centers had more disturbed sleep and that the informant reports reflected that fact. The UDS did not collect data on household sleeping arrangements, which makes it impossible to know whether some informants might not be missing sleep disturbance, for example, by not sleeping in the same bedroom as the patients. Data such as these might enhance the understanding of these apparent site differences. However, this type of influence would not be expected to operate systematically at different sites and vary systematically between DLB and AD cases. On the other hand, the possibility exists that different centers might implicitly weight the informant's report of NSD differently when establishing a diagnosis of DLB. Although RBD is now acknowledged to represent a strongly suggestive feature of DLB [1] , it is unclear how various centers may view these data as crucial or not crucial for establishing this differential diagnosis relative to AD. If the latter situation even represents the most remote possibility, it certainly draws attention to the importance of an independent and more detailed assessment of sleep/wake function in the evaluation of all dementia patients, perhaps even physiologically. For example, we have recently noted that phasic muscle activity in limbs [34] , recorded from a single REM sleep period, is a useful objective physiologic marker to differentiate individuals with a history of RBD from controls, even when dream enactment behaviors were not detected when sleeping in the laboratory for a single night [35] . Such electromyographic activity, labeled the phasic electromyographic metric (PEM), may provide objective verification of the phenomena that informants are providing here via the NPI-Q. Such measures may also be particularly informative by providing insights into the underlying neurodegenerative disorder in the clinical setting of mild cognitive impairment when the other more 'classic' features of AD and DLB have not yet become manifest. C DR SOB represents each unit increase in SOB. Center 6 was used as reference group because it contained the largest number of DLB patients.
